ReviewInternational journal of nanomedicine2025
Understanding the Molecular Toxicity of Metal-Based Nanoparticles Through Nanotoxicomics.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering Nanoscale Frontiers: Valve Metal Oxide Nanostructures From Fundamentals to Multifunctional Biomedical Applications.Chemical record (New York, N.Y.) · 2026Review
- From gut-reproductive microbiota to ferroptosis: a comprehensive insight into the molecular-pathogenicity of endometriosis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal and metal oxide nanoparticles (NPs) are prevalent in industrial, medical, and consumer applications, yet concerns persist regarding their potential impact on human health. Traditional endpoint-based toxicological studies often face challenges in explaining the complex molecular mechanisms underlying the interactions between the physicochemical properties of NPs (eg, chemical composition, size, coating) and biological factors (eg, cell type). To address this gap, we introduce nanotoxicomics, a stepwise framework that integrates nanotoxicology with advanced omics technologies-transcriptomics, proteomics, and metabolomics. This approach enables multilevel analysis of NP effects, supporting the extrapolation of in vitro findings to tissues, organs, or whole systems. Moreover, this framework provides insights into the molecular mechanisms underlying consumer-product interactions and occupational exposure to NPs by enabling early detection of transcriptomic biomarkers, guiding downstream proteomic validation, and supplying metabolomic functional readouts that can be translated into potential clinical outcomes and enhanced risk assessment strategies. This review compiles and critically discusses evidence on the interactions of metal and metal oxide NPs with human cells and occupationally exposed populations. Key mechanisms include differential expression of genes related to oxidative stress, inflammation, and DNA damage (eg, SOD1, IL-6, MAP3K14, TP53), validation of protein biomarkers such as heat shock proteins and metallothioneins, and metabolite shifts reflecting ATP depletion, mitochondrial dysfunction, and redox imbalance (eg, GSH, PGE2, ATP). Finally, we highlight the value of nanotoxicomics and bioinformatics for designing safer NPs that can function as nanosensors, real-time monitoring agents, and drug delivery systems in nanomedicine, particularly in oncology, neurology, immunology, and cardiology. Overall, this study provides valuable insights into the molecular basis of metal and metal oxide nanoparticles and lays the groundwork for future research in predictive nanotoxicology, biomonitoring, and omics-driven risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.